Dr. Eduard Zhalovaga is a distinguished Senior Medical Director with over 15 years of experience in the pharmaceutical and biotech industries. Throughout his career, he has led clinical development initiatives across Phase 1-3 trials in diverse therapeutic areas, including oncology, immunology, endocrinology, neurology, and gene therapy. His expertise in medical monitoring and strategic planning has been instrumental in advancing global clinical programs at renowned organizations such as AstraZeneca, Pfizer, MSD, Ipsen, and GE Healthcare.
Beyond his clinical work, Dr. Zhalovaga has played a pivotal role in pharmaceutical acquisitions, conducting due diligence for high-profile deals and navigating complex regulatory frameworks with authorities such as the FDA and EMA. His leadership has consistently driven innovation, ensuring the successful development of cutting-edge therapies while maintaining the highest standards of patient safety. In addition, he is deeply engaged with key opinion leaders (KOLs) and actively contributes to shaping the future of healthcare through advisory boards and thought leadership.
